Sio Capital Management as of March 31, 2015
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 29 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 34.4 | $61M | 525k | 115.28 | |
| Quotient | 10.9 | $19M | 1.1M | 17.00 | |
| Pfenex | 5.9 | $10M | 653k | 15.94 | |
| Johnson & Johnson (JNJ) | 5.4 | $9.6M | 95k | 100.60 | |
| Merck & Co (MRK) | 4.7 | $8.3M | 145k | 57.48 | |
| Eli Lilly & Co. (LLY) | 4.1 | $7.3M | 100k | 72.65 | |
| AstraZeneca (AZN) | 3.9 | $6.8M | 100k | 68.43 | |
| United Therapeutics Corporation (UTHR) | 3.4 | $6.0M | 35k | 172.42 | |
| Cardinal Health (CAH) | 3.0 | $5.2M | 58k | 90.28 | |
| Adamis Pharmaceuticals Corp Com Stk | 2.6 | $4.6M | 1.2M | 3.94 | |
| Addus Homecare Corp (ADUS) | 2.5 | $4.4M | 190k | 23.02 | |
| Cerner Corporation | 2.2 | $3.9M | 54k | 73.25 | |
| Abbvie (ABBV) | 1.8 | $3.2M | 55k | 58.55 | |
| UnitedHealth (UNH) | 1.8 | $3.1M | 27k | 118.30 | |
| Aratana Therapeutics | 1.6 | $2.9M | 179k | 16.01 | |
| Celladon | 1.5 | $2.6M | 139k | 18.94 | |
| Triple-S Management | 1.3 | $2.2M | 112k | 19.88 | |
| D Stemline Therapeutics | 1.1 | $2.0M | 140k | 14.47 | |
| Heron Therapeutics (HRTX) | 1.1 | $2.0M | 137k | 14.55 | |
| Forward Pharma A/s | 1.1 | $1.9M | 68k | 28.32 | |
| Agile Therapeutics | 1.1 | $1.9M | 204k | 9.27 | |
| Harvard Apparatus Regener Te | 0.8 | $1.5M | 456k | 3.25 | |
| Mirati Therapeutics | 0.8 | $1.4M | 47k | 29.33 | |
| Scynexis | 0.7 | $1.3M | 153k | 8.30 | |
| Tg Therapeutics (TGTX) | 0.7 | $1.2M | 77k | 15.48 | |
| Tokai Pharmaceuticals | 0.5 | $930k | 82k | 11.30 | |
| Inspiremd | 0.4 | $713k | 2.2M | 0.32 | |
| Merit Medical Systems (MMSI) | 0.3 | $467k | 24k | 19.27 | |
| BioDelivery Sciences International | 0.1 | $201k | 169k | 1.19 |
